[go: up one dir, main page]

AU3898000A - Treatment of neuropathic pain or fibromyalgia - Google Patents

Treatment of neuropathic pain or fibromyalgia

Info

Publication number
AU3898000A
AU3898000A AU38980/00A AU3898000A AU3898000A AU 3898000 A AU3898000 A AU 3898000A AU 38980/00 A AU38980/00 A AU 38980/00A AU 3898000 A AU3898000 A AU 3898000A AU 3898000 A AU3898000 A AU 3898000A
Authority
AU
Australia
Prior art keywords
fibromyalgia
treatment
neuropathic pain
neuropathic
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38980/00A
Inventor
Carl M. Mendel
Timothy B. Seaton
Steve P. Weinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Knoll Pharmaceutical Co
Original Assignee
Knoll Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Pharmaceutical Co filed Critical Knoll Pharmaceutical Co
Publication of AU3898000A publication Critical patent/AU3898000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU38980/00A 1999-03-19 2000-03-17 Treatment of neuropathic pain or fibromyalgia Abandoned AU3898000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12511399P 1999-03-19 1999-03-19
US60125113 1999-03-19
PCT/US2000/007204 WO2000056318A1 (en) 1999-03-19 2000-03-17 Treatment of neuropathic pain or fibromyalgia

Publications (1)

Publication Number Publication Date
AU3898000A true AU3898000A (en) 2000-10-09

Family

ID=22418242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38980/00A Abandoned AU3898000A (en) 1999-03-19 2000-03-17 Treatment of neuropathic pain or fibromyalgia

Country Status (2)

Country Link
AU (1) AU3898000A (en)
WO (1) WO2000056318A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
JP5405571B2 (en) * 2008-07-24 2014-02-05 セラヴァンス， インコーポレーテッド 3- (phenoxyphenylmethyl) pyrrolidine compound
AR095036A1 (en) 2013-03-14 2015-09-16 Kalyra Pharmaceuticals Inc BICYCLIC ANALGESTIC COMPOUNDS
WO2015089170A1 (en) 2013-12-12 2015-06-18 Kalyra Pharmaceuticals, Inc. Bicyclic alkyl compounds and synthesis
CN113336653A (en) 2014-03-07 2021-09-03 里科瑞尔姆Ip控股有限责任公司 Propalane derivatives and synthesis
CN106999451B (en) 2014-09-17 2021-04-02 里科瑞尔姆Ip控股有限责任公司 bicyclic compounds
WO2017160926A1 (en) * 2016-03-16 2017-09-21 Kalyra Pharmaceuticals, Inc. Analgesic compounds
BR112019024155A2 (en) 2017-05-15 2020-06-02 Recurium Ip Holdings, Llc ANALGESIC COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver

Also Published As

Publication number Publication date
WO2000056318A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
AU7906100A (en) Use of retigabin for treating neuropathic pain
GB9824436D0 (en) Methods of treatment
AU3784999A (en) Methods for treatment of pain
AU3898000A (en) Treatment of neuropathic pain or fibromyalgia
AU2740899A (en) Treatment of liquids
AU3896900A (en) Treatment of pain
AU2512501A (en) Use of trimebutine for treating pain
AU7756900A (en) Treatment of chemical hydrolysates
AU2566201A (en) Compounds and methods for the treatment of pain
AU2420101A (en) Method and composition for the treatment of pain
AU5824800A (en) Use of fosphenytoin for the treatment of acute neuropathic pain
AU4598400A (en) Method of treatment
AU2619199A (en) Treatment of waxes
AU2683500A (en) Compositions for the treatment of pain
AU2420201A (en) Compounds and methods for the treatment of pain
AU2382601A (en) Novel method of treatment
AU6112299A (en) Treatment of effluents
AU8557598A (en) Treatment of fluids
AU2002315238A1 (en) Treatment of neuropathic pain
AUPQ421299A0 (en) Treatment of bone disorder
AUPP571098A0 (en) Method of treatment of animals
AU4014800A (en) Treatment of gallstones
AU5294499A (en) Treatment of hair loss
AUPQ385599A0 (en) Treatment of hypercholesterolaemia
AUPQ320299A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase